Antimicrobial Agents in Clinical Treatment

It is an analysis of the antibacterial clinical development pipeline, including mycobacterium tuberculosis. Resistance is a natural phenomenon which will develop by time. As misuse and overuse of antibiotics at accelerate the development of resistance. Antibiotics should be used for antibacterial treatment. The lack of new quality lead chemicals to test against gram-ve bacteria is another major impediment to discovery.

 

  • Vaccines against human papillomavirus
  • Phytotherapy
  • Ethnopharmacology

Related Conference of Antimicrobial Agents in Clinical Treatment

November 21-22, 2024

7th Pathology and Infectious Disease Conference

Dubai, UAE
November 28-29, 2024

20th World Congress on Infection Prevention and Control

Paris, France
March 13-14, 2025

9th International Conference on Rare Diseases

Prague, Czech Republic
March 17-18, 2025

12th International Congress on Infectious Diseases

Berlin, Germany
April 14-15, 2025

15th European Epidemiology and Public Health Congress

Budapest, Hungary
June 02-03, 2025

17th Euro-Global Conference on Infectious Diseases

Amsterdam, Netherlands
June 02-03, 2025

14th World Congress on Rare Diseases and Orphan Drugs

Amsterdam, Netherlands

Antimicrobial Agents in Clinical Treatment Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in